NCT07641790 Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients
| NCT ID | NCT07641790 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Faisalabad |
| Condition | Hemiplegia |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-02-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Eligibility Criteria
Inclusion Criteria: * Unilateral hemiplegia secondary to stroke * Age between 30 and 60 years * Subacute stage (3 to 6 months post-stroke) * Fugl-Meyer Assessment (FMA) score between 20 and 50 * Able to follow simple verbal commands Exclusion Criteria: * Previous peripheral nerve injury or surgery affecting the upper limb * Fixed contractures or bony fractures in the affected limb * Complete sensory loss of the upper limb * Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia) * Unstable cardiovascular conditions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07641790 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Hemiplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07641790 currently recruiting?
Yes, NCT07641790 is actively recruiting participants. Contact the research team at anbreenarasool.DPT@tuf.edu.pk for enrollment information.
Where is the NCT07641790 trial being conducted?
This trial is being conducted at Faisalābad, Pakistan.
Who is sponsoring the NCT07641790 clinical trial?
NCT07641790 is sponsored by University of Faisalabad. The trial plans to enroll 30 participants.